China Healthcare

China Healthcare
  • Pininvest Analysis

No one doubts health care in China is becoming an ever bigger story and no one will be surprised to see the Chinese authorities focus doggedly on strengthening the country’s pharmaceutical expertise

With most of the pharmaceutical businesses quoted on Chinese stock markets, American investors may be advised to refer to our theme of US listed companies as informative – but partial – guidelines regarding some of the Chinese health care trends

  • Not all the OTC-listed companies appear to be actively traded, though successfully introduced on the Chinese market
  • High valuations may in many cases reflect a tendency of the Chinese investors to ‘overshoot’ in a spurt of optimism

The overall growth perspectives, and the will to ensure Chinese companies are the immediate beneficiaries, are unquestionable – foreign providers, such as Novo Nordisk of Denmark NVO/NYSE in the diabetes market, are well aware of the challenge

Read our notes

China Healthcare • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Momentum Vol. Risk Contrib. MDD
 
Alibaba Health Information Technology ALBHF OTC Health Care Healthcare Supply Chain & InfoTech USD 3.46 - 87.0% Strong Up 86%   8% -30%
BeiGene BGNE NASDAQ Health Care Gene Editing - Cell Therapies USD 320.00 29 B 102.1% Neutral 56%   7% -30%
Cellular Biomedicine CBMG NASDAQ Health Care Biopharmaceuticals USD 19.75 384 M 23.7% Weak Up 63%   7% -32%
Concord Medical Services CCM NYSE Health Care Healthcare Facilities & Services USD 3.60 156 M 56.5% Neutral 152%   18% -49%
CSPC Pharmaceutical Group CHJTF OTC Health Care Drug Manufacturers - Diversified USD 1.03 - -14.7% Neutral 74%   2% -49%
Genscript Biotech GNNSF OTC Health Care Biopharmaceuticals USD 1.79 - -15.6% Weak Up 73%   4% -44%
Guangzhou Baiyunshan Pharmaceutical Holdings GZPHF OTC Health Care Drug Manufacturers - Diversified USD 2.50 - -29.9% Neutral 26%   0% -34%
Hutchison China MediTech HCM NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 28.74 3.8 B 23.2% Neutral 59%   8% -40%
Novo Nordisk NVO NYSE Health Care Diabetes USD 71.25 168 B 24.8% Neutral 31%   4% -24%
Shandong Weigao Group Medical SHWGY OTC Health Care Medical Consumables & Intermediates USD 7.03 - 31.5% Neutral 56%   5% -37%
Shanghai Fosun Pharmaceutical SFOSF OTC Health Care Drug Manufacturers - Diversified USD 4.63 - 67.3% Neutral 66%   6% -26%
Shanghai Pharmaceuticals SHPMY OTC Health Care Drug Manufacturers - Diversified USD 9.48 - 4.0% Neutral 66%   5% -28%
Sino Biopharmaceutical SBMFF OTC Health Care Drug Manufacturers - Diversified USD 1.08 - 19.2% Neutral 61%   5% -44%
Sinopharm Group SHTDF OTC Health Care Drug Manufacturers - Diversified USD 2.36 - -21.6% Neutral 55%   4% -36%
Tong Ren Tang Technologies TGRNF OTC Health Care Drug Manufacturers - Diversified USD 0.62 - -30.3% Neutral 32%   1% -33%
WuXi Biologics (Cayman) WXXWY OTC Health Care Medical Laboratories & Research USD 25.25 - 159.2% Neutral 88%   10% -53%
Zai Lab ZLAB NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 147.52 8.6 B 168.4% Neutral 59%   8% -23%